Filing Details

Accession Number:
0000849146-23-000117
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-07 16:06:57
Reporting Period:
2023-09-05
Accepted Time:
2023-09-07 16:06:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849146 Lifevantage Corp LFVN Pharmaceutical Preparations (2834) 841097796
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436020 Paul Garry Mauro 3300 Triumph Blvd, Suite 700
Lehi UT 84043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-05 425 $7.63 64,189 No 4 P Direct
Common Stock Acquisiton 2023-09-05 110 $7.63 25,280 No 4 P Indirect By The Francesco A. Mauro Trust of 2021
Common Stock Acquisiton 2023-09-05 110 $7.63 25,280 No 4 P Indirect By The Andrew H. Mauro Trust of 2021
Common Stock Acquisiton 2023-09-05 110 $7.63 25,280 No 4 P Indirect By The David W.B. Mauro Trust of 2021
Common Stock Acquisiton 2023-09-05 110 $7.63 25,280 No 4 P Indirect By The Dominic C. Mauro Trust of 2021
Common Stock Acquisiton 2023-09-05 110 $7.63 25,280 No 4 P Indirect By The Alexandra P. Mauro Trust of 2021
Common Stock Acquisiton 2023-09-05 25 $7.63 25 No 4 P Indirect By Garry Paul Mauro SEP IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By The Francesco A. Mauro Trust of 2021
No 4 P Indirect By The Andrew H. Mauro Trust of 2021
No 4 P Indirect By The David W.B. Mauro Trust of 2021
No 4 P Indirect By The Dominic C. Mauro Trust of 2021
No 4 P Indirect By The Alexandra P. Mauro Trust of 2021
No 4 P Indirect By Garry Paul Mauro SEP IRA